No Data
No Data
Tenax Therapeutics | 10-K: Annual report
Tenax Therapeutics | 8-K: Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Express News | Tenax Therapeutics Q4 2024 GAAP EPS $(0.18) Beats $(0.42) Estimate
Tenax Therapeutics Completed Private Placements With Proceeds of About $125 M to Support Studies for TNX-103, Fund Ops Through 2027 >TENX
Express News | Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Tenax Therapeutics 4Q Loss/Shr 18c >TENX